Skip to main content
Top

16-05-2018 | Juvenile idiopathic arthritis | Review | Article

Vitamin D and juvenile idiopathic arthritis

Journal: Pediatric Rheumatology

Authors: Sarah L. Finch, Alan M. Rosenberg, Hassan Vatanparast

Publisher: BioMed Central

Abstract

Background

Vitamin D has been implicated in the pathogenesis of autoimmune diseases. While the roles of vitamin D in other autoimmune diseases have been investigated, less is known about the role of vitamin D in chronic childhood arthritis.

Main body

This review summarizes and evaluates evidence relating to 25-hydroxyvitamin D (25(OH)D) and chronic childhood arthritis. A scoping literature review was conducted using Ovid Medline, Ovid Embase, Cumulative Index to Nursing and Allied Health Literature, Web of Science and Scopus. Further, we geo-mapped the results of the studies to identify the patterns of the association between vitamin D and chronic childhood arthritis across the globe. Of 38 studies reporting 25(OH)D concentrations in childhood chronic arthritis, 32 (84.2%) reported that a significant number of children had suboptimal (< 75 nmol/L) status.

Conclusion

The data indicate suboptimal vitamin D status in children with chronic arthritis. Further, the association between low vitamin D and increased arthritis activity follow a north-south geographical gradient.
Literature
1.
Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis - why does it vary so much? J Rheumatol. 2002;29:1520–30.PubMed
2.
Brewer EJ Jr, Bass J, Baum J, Cassidy JT, Fink C, Jacobs J, Hanson V, Levinson JE, Schaller JSJ. Current proposed revision of JRA criteria. JRA criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American rheumatism section of the Arthritis Foundation. Arthritis Rheum. 1977;20:195–9.PubMed
3.
Woods P. Special meeting on nomenclature and classification of arthritis in children. Basel: EULAR Publishers; 1978. p. 47–50.
4.
Von Scheven E, Burnham JM. Vitamin D supplementation in the pediatric rheumatology clinic. Curr Rheumatol Rep. 2011;13:110–6.CrossRefPubMedPubMedCentral
5.
Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol. 2013;45:256–66.CrossRefPubMed
6.
Cutolo M, Pizzorni C, Sulli A. Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun Rev. 2011;11:84–7.CrossRefPubMed
7.
Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Rheum Dis Clin N Am. 2012;38:125–39.CrossRef
8.
Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008;4:404–12.CrossRefPubMed
9.
Holick MF. Vitamin D: Extraskeletal Health. Rheum Dis Clin N Am. 2012;38:141–60.CrossRef
10.
Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10:482–96.CrossRefPubMed
11.
Sabbagh Z, Markland J, Vatanparast H. Vitamin D status is associated with disease activity among rheumatology outpatients. Nutrients. 2013;5:2268–75.CrossRefPubMedPubMedCentral
12.
Nisar MK, Masood F, Cookson P, Sansome A, Ostör AJK. What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence. Clin Rheumatol. 2013;32:729–34.CrossRefPubMed
13.
Daudt HM, van Mossel C, Scott SJ. Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework. BMC Med Res Methodol. 2013;13:48.CrossRefPubMedPubMedCentral
14.
Arksey H, Malley LO. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32.CrossRef
15.
Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69.CrossRefPubMedPubMedCentral
16.
Colquhoun HL, Levac D, O’Brien KK, Straus S, Tricco AC, Perrier L, et al. Scoping reviews: time for clarity in definition, methods, and reporting. J Clin Epidemiol. 2014;67:1291–4.CrossRefPubMed
17.
Petty R, Southwood T, Manners P. International league of associations for rheumatology. International league of associations for rheumatology classification of juvenile idiopathic arthritis. J Rheumatol. 2004;31:390–2.PubMed
18.
Moher D, Liberati A, Tetzlaff J, Altman DG. Systematic reviews and meta-analyses: the PRISMA statement. Annu Intern Med. 2009;151:264–9.CrossRef
19.
Institute of Medicine. Food and nutrition board, dietary reference intakes for calcium and vitamin D. Washington: National Academy Press; 2010.
20.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.CrossRefPubMed
21.
Dağdeviren-çakır A, Arvas A, Barut K, Gür E, Kasapçopur Ö. Serum vitamin D levels during activation and remission periods of patients with juvenile idiopathic arthritis and familial Mediterranean fever. Turk J Pediatr. 2016;58:125–31.CrossRefPubMed
22.
de Sousa Studart SA, Leite AC, Marinho AL, Pinto AC, Rabelo Júnior CN, de Melo NR, et al. Vitamin D levels in juvenile idiopathic arthritis from an equatorial region. Rheumatol Int. 2015;35:17–23.CrossRef
23.
Stagi S, Bertini F, Cavalli L, Matucci-cerinic M, Brandi ML, Falcini F. Determinants of vitamin D levels in children, adolescents, and young adults with juvenile idiopathic arthritis determinants of vitamin D levels in children, adolescents, and young adults with juvenile idiopathic arthritis. J Rheumatol. 2014;41:1884–92.CrossRefPubMed
24.
Szymańska-Kałuża J, Biernacka-ZielińskaM, Stańczyk J, Smolewska E. Vitamin D level in children with juvenile idiopathic arthritis and its correlation with clinical picture of the disease. Reumatologia. 2013;51:271–6.CrossRef
25.
Munekata RV, Terreri MTRA, Peracchi OAB, Len C. Serum 25-hydroxyvitamin D and biochemical markers of bone metabolism in patients with juvenile idiopathic arthritis. Braz J Med Biol Res. 2013;46:98–102.CrossRefPubMedPubMedCentral
26.
Lien G, Selvaag AM, Flatø B, Haugen M, Vinje O, Sørskaar D, et al. A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis. Arthritis Rheum. 2005;52:833–40.CrossRefPubMed
27.
Tang X. Mingyue L. Association between vitamin D concentrations with disease activity and bone mineral density of juvenile idiopathic arthritis patients. International Journal of Rheumatic Diseases. Conference: 18th Asia Pacific League of Associations for Rheumatology Congress, APLAR. China. 2016. Conference Start 20160926. Conference End: 20160929. 2016;19:158.
28.
Alhomaidah D, Alsagheir A, Al-mayouf SM. ScienceDirect coexistence of endocrinopathies in children with rheumatic diseases. Int J Pediatr Adolesc Med. 2016;3:119–22.CrossRef
29.
Goralczyk A, Konstantynowicz J, Abramowicz P, Dobrenko E, Babinska-Malec E. Deficits of vitamin D are strongly associated with methotrexate treatment in patients with juvenile idiopathic arthritis. Bone Abstr. 2015;183
30.
Peixoto D, Teixeira F, Lucas R, Costa J, Costa L, AD. Vitamin D status in patients with juvenile idiopathic arthritis. Ann. Rheum. Dis. Conf. Annu. Eur. Congr. Rheumatol. Eur. Leag. Against Rheum. EULAR. 2012;2013:71.
31.
Dey S, Jahan A, Yadav TP, Bhagwani DK, Sachdev N. Measurement of bone mineral density by dual energy X-ray absorptiometry in juvenile idiopathic arthritis. Indian J Pediatr. 2014;81:126–32.CrossRefPubMed
32.
Çomak E, Doğan ÇS, Uslu-gökçeoğlu A, Akbaş H, Özdem S. Association between vitamin D deficiency and disease activity in juvenile idiopathic arthritis. Turk J Pediatr. 2014;56:626–31.PubMed
33.
Bouaddi I, Rostom S, El Badri D, Hassani A, Chkirate B, Abouqal R, et al. Vitamin D concentrations and disease activity in Moroccan children with juvenile idiopathic arthritis. BMC Musculoskelet Disord. 2014;15:115.CrossRefPubMedPubMedCentral
34.
Miettinen ME, Kinnunen L, Harjutsalo V, Reinert-Hartwall L, Lamberg-Allardt C, Toumilehto J, Saila H. Serum 25-hydroxyvitamin D in juvenile idiopathic arthritis patients in Finland-letters to the editors. Clin Exp Rheumatol. 2013;31:988.PubMed
35.
Nisar M, Cookson P, Masood F, Sansome A, Ostor A. Is there a link between vitamin D and juvenile idiopathic arthritis? Ann Rheum Dis Conf Annu Eur Congr Rheumatol Eur Leag Against Rheum EULAR. Conference Start: 20130612. Conference End:20130615.2013:72.
36.
Pelajo CF, Lopez-Benitez JM, Kent DM, Price LL, Miller LC, Dawson-Hughes B. 25-hydroxyvitamin D levels and juvenile idiopathic arthritis: is there an association with disease activity? Rheumatol Int. 2012;32:3923–9.CrossRefPubMed
37.
Markula-patjas KP, Valta HL, Kerttula LI, Soini IH, Honkanen VEA, Mäkitie OM, et al. Prevalence of vertebral compression fractures and associated factors in children and adolescents with severe juvenile idiopathic arthritis prevalence of vertebral compression fractures and associated factors in children and adolescents with severe Juvenil. J Rheumatol. 2012;39:365–73.CrossRefPubMed
38.
Valta H, Lahdenne P, Jalanko H, Aalto K. Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis. J Rheumatol. 2007;34:831–6.PubMed
39.
Rosiles VH, Salazar CD, Velazquez RM, Ruiz RR, CP. Determination of 25(OH)D serum levels in children with systemic lupus erythematosus and juvenile idiopathic arthritis. Bol Med del Hosp Infant Mex. 2015;72:99–105.
40.
Siamopoulou A, Challa A, Kapoglou P, Cholevas V, Mavridis AK, Lapatsanis PD. Effects of intranasal salmon calcitonin in juvenile idiopathic arthritis: an observational study. Calcif Tissue Int. 2001;69:25–30.CrossRefPubMed
41.
Bianchi ML, Bardare M, Caraceni MP, Cohen E, Falvella S, Borzani M, et al. Bone metabolism in juvenile rheumatoid arthritis. Bone Miner. 1990;9:153–62.CrossRefPubMed
42.
Reed AM, Haugen M, Pachman LM, Langman CB. Repair of osteopenia in children with juvenile rheumatoid arthritis. J Pediatr. 1993;122:693–6.CrossRefPubMed
43.
Pepmueller PH, Cassidy JT, Allen SH, Hillman LS. Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1996;39:746–57.CrossRefPubMed
44.
Henderson CJ, Cawkwell GD, Specker BL, Sierra RI, Wilmott RW, Campaigne BN, et al. Non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum. 1997;40:1967–75.CrossRefPubMed
45.
Stark LJ, Davis AM, Janicke DM, Mackner LM, Hommel KA, Bean JA, Lovell D, Heubi JE, KH. A randomized clinical trial of dietary calcium to improve bone accretion in children with juvenile rheumatiod arthritis. Pediatrics. 2006;148:501–7.CrossRef
46.
Reed A, Haugen M, Pachman LM, Langman CB. 25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density. J Pediatr. 1991;119:657–60.CrossRefPubMed
47.
Hillman L, Cassidy JT, Johnson L, Lee D, Allen SH. Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis. J Pediatr. 1994;124:910–6.CrossRefPubMed
48.
Falcini F, Ermini M, Bagnoli F. Bone turnover is reduced in children with juvenile rheumatoid arthritis. J Endocrinol Investig. 1998;21:31–6.CrossRef
49.
Rooney M, Davies UM, Reeve J, Preece M, Ansell BM, WP. Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis. J Rheumatol. 2000;27:1073–81.PubMed
50.
Tzoufi M, Siamopoulou-Mavridou A, Challa A, Lapatsanis PD. Changes of mineral metabolism in juvenile chronic arthritis. Acta Paediatr Suppl. 1994;394:52–7.CrossRefPubMed
51.
Elsasser U, Wilkins B, Hesp R, Thurnham DI, Reeve J, Ansell BM. Bone rarefaction and crush fractures in juvenile chronic arthritis. Arch Dis Child. 1982;57:377–80.CrossRefPubMedPubMedCentral
52.
Johansson U, Portinsson S, Akesson A, Svantesson H, Ockerman PA, Akesson B. Nutritional status in girls with juvenile arthritis. Hum Nutr - Clin Nutr. 1986;41:57–67.
53.
Reeve J, Loftus J, Hesp R, Ansell BM, Wright DJ, Woo PMM. Biochemical prediction of changes in spinal bone mass in juvenile chronic (or rheumatoid) arthritis treated with glucocorticoids. J Rheumatol. 1993;20:1189–95.PubMed
54.
Hillman LS, Cassidy JT, Chanetsa F, Hewett JE, Higgins BJ, Robertson JD. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium. Arthritis Rheum. 2008;58:3255–63.CrossRefPubMed
55.
Warady BD, Lindsley CB, Robinson FG, LB. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy. J Rheumatol. 1994;21:530–5.PubMed
56.
McNally JD, Menon K, Chakraborty P, Fisher L, Williams KA, Al-Dirbashi OY, et al. The Association of Vitamin D Status with Pediatric Critical Illness. Pediatrics. 2012;130:429–36.CrossRefPubMed
57.
Reed A, Haugen M, Pachman LM, Langman CB. Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases. J Pediatr. 1990;116:574–80.CrossRefPubMed
58.
Pelajo CF, Lopez-Benitez JM, Miller LC. Obesity and disease activity in juvenile idiopathic arthritis. Pediatr Rheumatol. 2012;10:3.CrossRef
59.
McNally JD, Matheson LA, Rosenberg AM. Epidemiologic considerations in unexplained pediatric arthralgia: the role of season, school, and stress. J Rheumatol. 2009;36:427–33.PubMed
60.
Wang Y, Lu MP, Teng LP, Guo L, Xu YP, Zou LX, et al. Association of vitamin D concentrations with juvenile idiopathic arthritis. Zhongguo Dang Dai Er Ke Za Zhi. 2015;17:375–8.PubMed
61.
Borchers AT, Selmi C, Cheema G, Keen CL, Shoenfeld Y, Gershwin ME. Juvenile idiopathic arthritis. Autoimmun Rev. 2006;5:279–98.CrossRefPubMed
62.
Holick MF. Biological effects of sunlight, ultraviolet radiation, visible light, infrared radiation and vitamin D for health. Anticancer Res. 2016;36:1345–56.PubMed
63.
Tsiaras WG, Weinstock MA. Factors influencing vitamin d status. Acta Derm Venereol. 2011;91:115–24.CrossRefPubMed
64.
Wacker M, Holick MF. Sunlight and vitamin D: a global perspective for health. Dermatoendocrinol. 2013;5:51–108.CrossRefPubMedPubMedCentral
65.
Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988;67:373–8.CrossRefPubMed
66.
Rosiles VH, Salazar CD, Velazquez RM, Ruiz RR, Clark P. Determination of 25(OH)D serum levels in children with systemic lupus erythematosus and juvenile idiopathic arthritis. Bol Med Hosp Infant Mex. 2015;72:99–105.PubMed
67.
Duffy CM. Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: clinical science for the pediatrician. Rheum Dis Clin N Am. 2007;33:389–402.CrossRef
68.
Ringold S, Wallace CA. Measuring clinical response and remission in juvenile idiopathic arthritis. Curr Opin Rheumatol. 2007;19:471–6.CrossRefPubMed
69.
Ringold S, Weiss PF, Beukelman T, Dewitt EM, Ilowite NT, Kimura Y, et al. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among c. Arthritis Care Res. 2013;65:1551–63.CrossRef
70.
Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential. Front Immunol. 2017;7:697.CrossRefPubMedPubMedCentral
71.
Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun Rev. 2007;7:59–64.CrossRefPubMed
72.
Vojinovic J, Cimaz R. Vitamin D—update for the pediatric rheumatologists. Pediatr Rheumatol Online J. 2015;13:18.CrossRefPubMedPubMedCentral
73.
Gröber U, Spitz J, Reichrath J, Kisters K, Holick MF. Vitamin D: update 2013 - from rickets prophylaxis to general preventive healthcare. Dermatoendocrinol. 2013;5:331–47.CrossRefPubMedPubMedCentral
74.
Gröber U, Kisters K. Influence of drugs on vitamin D and calcium metabolism. Dermatoendocrinol. 2012;4:158–66.CrossRefPubMedPubMedCentral
75.
Soybilgic A, Tesher M, Wagner-Weiner L, Onel KB. A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America. Pediatr. Rheumatol. Online J. 2014;12:24.CrossRefPubMedPubMedCentral
76.
Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum. 2007;56:1974–84.CrossRefPubMed
77.
Ellis JA, Ponsonby A-L, Pezic A, Chavez RA, Allen RC, Akikusa JD, et al. CLARITY - ChiLdhood arthritis risk factor identification sTudY. Pediatr Rheumatol Online J. 2012;10:–37.
78.
Thorsen S, Pipper C, Alberdi-Saugstrup M, Nielsen S, Cohen A, Lundqvist M, et al. No association between vitamin D levels around time of birth and later risk of developing oligo- and polyarticular juvenile idiopathic arthritis: a Danish case–cohort study. Scand J Rheumatol. 2016;9742:1–8.
79.
Falcini F, Marini F, Rigante D, Bertini F, Lepri G, Stagi S, et al. PReS-FINAL-2053: vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis. Pediatr Rheumatol. 2013;11:P66.CrossRef
80.
Ellis JA, Scurrah KJ, Li YR, Ponsonby A-L, Chavez RA, Pezic A, et al. Epistasis amongst PTPN2 and genes of the vitamin D pathway contributes to risk of juvenile idiopathic arthritis. J Steroid Biochem Mol Biol. 2015;145:113–20.CrossRefPubMed
81.
Consolaro A, Bracciolini G, Ruperto N, Pistorio A, Magni-Manzoni S, Malattia C, et al. Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. Arthritis Rheum. 2012;64:2366–74.CrossRefPubMed
82.
Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40:1202–9.CrossRefPubMed
83.
Berkun Y, Lewy H, Padeh S, Laron Z, Centre SM, Hashomer T. Seasonality of birth of patients with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2015;33:122–6.PubMed
84.
Carlens C, Jacobsson L, Brandt L, Cnattingius S, Stephansson O, Askling J. Perinatal characteristics, early life infections and later risk of rheumatoid arthritis and juvenile idiopathic arthritis. Ann Rheum Dis. 2009;68:1159–64.CrossRefPubMed